Logo image of ICG

INTCHAINS GROUP LTD-ADR (ICG) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:ICG - US45828E1047 - ADR

2.17 USD
+0.07 (+3.33%)
Last: 1/21/2026, 8:00:03 PM
Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to ICG. ICG was compared to 113 industry peers in the Semiconductors & Semiconductor Equipment industry. While ICG has a great health rating, there are worries on its profitability. While showing a medium growth rate, ICG is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

  • ICG had positive earnings in the past year.
  • ICG had positive earnings in 4 of the past 5 years.
  • The reported operating cash flow has been mixed in the past 5 years: ICG reported negative operating cash flow in multiple years.
ICG Yearly Net Income VS EBIT VS OCF VS FCFICG Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 100M -100M 200M 300M 400M

1.2 Ratios

  • Looking at the Return On Assets, with a value of 7.96%, ICG is in the better half of the industry, outperforming 75.22% of the companies in the same industry.
  • ICG has a Return On Equity of 8.25%. This is in the better half of the industry: ICG outperforms 69.03% of its industry peers.
Industry RankSector Rank
ROA 7.96%
ROE 8.25%
ROIC N/A
ROA(3y)13.06%
ROA(5y)26.3%
ROE(3y)13.41%
ROE(5y)28.41%
ROIC(3y)N/A
ROIC(5y)N/A
ICG Yearly ROA, ROE, ROICICG Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 20 -20 40 60

1.3 Margins

  • With an excellent Profit Margin value of 35.25%, ICG belongs to the best of the industry, outperforming 94.69% of the companies in the same industry.
  • ICG's Profit Margin has declined in the last couple of years.
  • In the last couple of years the Operating Margin of ICG has declined.
  • The Gross Margin of ICG (36.86%) is worse than 60.18% of its industry peers.
  • ICG's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM N/A
PM (TTM) 35.25%
GM 36.86%
OM growth 3Y-50.5%
OM growth 5YN/A
PM growth 3Y-36.68%
PM growth 5YN/A
GM growth 3Y-13.04%
GM growth 5Y25.49%
ICG Yearly Profit, Operating, Gross MarginsICG Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 50 -50

9

2. Health

2.1 Basic Checks

  • ICG does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • ICG has about the same amout of shares outstanding than it did 1 year ago.
  • ICG has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
ICG Yearly Shares OutstandingICG Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
ICG Yearly Total Debt VS Total AssetsICG Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

  • ICG has an Altman-Z score of 15.13. This indicates that ICG is financially healthy and has little risk of bankruptcy at the moment.
  • ICG has a better Altman-Z score (15.13) than 81.42% of its industry peers.
  • There is no outstanding debt for ICG. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 15.13
ROIC/WACCN/A
WACC9.48%
ICG Yearly LT Debt VS Equity VS FCFICG Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M 1B

2.3 Liquidity

  • ICG has a Current Ratio of 16.57. This indicates that ICG is financially healthy and has no problem in meeting its short term obligations.
  • ICG has a better Current ratio (16.57) than 98.23% of its industry peers.
  • ICG has a Quick Ratio of 13.32. This indicates that ICG is financially healthy and has no problem in meeting its short term obligations.
  • With an excellent Quick ratio value of 13.32, ICG belongs to the best of the industry, outperforming 98.23% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 16.58
Quick Ratio 13.33
ICG Yearly Current Assets VS Current LiabilitesICG Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

6

3. Growth

3.1 Past

  • ICG shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 90.00%, which is quite impressive.
  • ICG shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -51.46% yearly.
  • Looking at the last year, ICG shows a small growth in Revenue. The Revenue has grown by 6.47% in the last year.
  • ICG shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 51.10% yearly.
EPS 1Y (TTM)90%
EPS 3Y-51.46%
EPS 5YN/A
EPS Q2Q%350%
Revenue 1Y (TTM)6.47%
Revenue growth 3Y-23.58%
Revenue growth 5Y51.1%
Sales Q2Q%-85.05%

3.2 Future

  • The Earnings Per Share is expected to decrease by -11.54% on average over the next years. This is quite bad
  • The Revenue is expected to grow by 11.95% on average over the next years. This is quite good.
EPS Next Y-22.74%
EPS Next 2Y-11.54%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-28.79%
Revenue Next 2Y11.95%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
ICG Yearly Revenue VS EstimatesICG Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 200M 400M 600M
ICG Yearly EPS VS EstimatesICG Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 0.02 0.04 0.06 0.08 0.1

0

4. Valuation

4.1 Price/Earnings Ratio

  • ICG is valuated quite expensively with a Price/Earnings ratio of 72.33.
  • ICG's Price/Earnings is on the same level as the industry average.
  • ICG's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 27.32.
  • The Price/Forward Earnings ratio is 148.46, which means the current valuation is very expensive for ICG.
  • 65.49% of the companies in the same industry are cheaper than ICG, based on the Price/Forward Earnings ratio.
  • ICG is valuated expensively when we compare the Price/Forward Earnings ratio to 24.30, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 72.33
Fwd PE 148.46
ICG Price Earnings VS Forward Price EarningsICG Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 50 100

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ICG Per share dataICG EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.5 1 1.5 2 2.5

4.3 Compensation for Growth

  • A cheap valuation may be justified as ICG's earnings are expected to decrease with -11.54% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-11.54%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

  • No dividends for ICG!.
Industry RankSector Rank
Dividend Yield 0%

INTCHAINS GROUP LTD-ADR

NASDAQ:ICG (1/21/2026, 8:00:03 PM)

2.17

+0.07 (+3.33%)

Chartmill FA Rating
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)11-13
Earnings (Next)N/A
Inst Owners0.22%
Inst Owner Change0%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap131.01M
Revenue(TTM)258.15M
Net Income(TTM)91.00M
Analysts80
Price Target3.57 (64.52%)
Short Float %0.95%
Short Ratio0.63
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)774.98%
Min EPS beat(2)42.23%
Max EPS beat(2)1507.72%
EPS beat(4)2
Avg EPS beat(4)338.39%
Min EPS beat(4)-136%
Max EPS beat(4)1507.72%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-71.04%
Min Revenue beat(2)-83%
Max Revenue beat(2)-59.09%
Revenue beat(4)1
Avg Revenue beat(4)-42.18%
Min Revenue beat(4)-83%
Max Revenue beat(4)9.68%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-30%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-36.57%
EPS NY rev (1m)0%
EPS NY rev (3m)1272.64%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-41.26%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-24.43%
Valuation
Industry RankSector Rank
PE 72.33
Fwd PE 148.46
P/S 3.53
P/FCF N/A
P/OCF N/A
P/B 0.83
P/tB 0.83
EV/EBITDA N/A
EPS(TTM)0.03
EY1.38%
EPS(NY)0.01
Fwd EY0.67%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS0.61
BVpS2.63
TBVpS2.62
PEG (NY)N/A
PEG (5Y)N/A
Graham Number1.33
Profitability
Industry RankSector Rank
ROA 7.96%
ROE 8.25%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 35.25%
GM 36.86%
FCFM N/A
ROA(3y)13.06%
ROA(5y)26.3%
ROE(3y)13.41%
ROE(5y)28.41%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-50.5%
OM growth 5YN/A
PM growth 3Y-36.68%
PM growth 5YN/A
GM growth 3Y-13.04%
GM growth 5Y25.49%
F-ScoreN/A
Asset Turnover0.23
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 16.58
Quick Ratio 13.33
Altman-Z 15.13
F-ScoreN/A
WACC9.48%
ROIC/WACCN/A
Cap/Depr(3y)583.15%
Cap/Depr(5y)424.89%
Cap/Sales(3y)21.73%
Cap/Sales(5y)13.21%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)90%
EPS 3Y-51.46%
EPS 5YN/A
EPS Q2Q%350%
EPS Next Y-22.74%
EPS Next 2Y-11.54%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)6.47%
Revenue growth 3Y-23.58%
Revenue growth 5Y51.1%
Sales Q2Q%-85.05%
Revenue Next Year-28.79%
Revenue Next 2Y11.95%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-192.5%
EBIT growth 3Y-62.17%
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-170.52%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-2829.94%
OCF growth 3YN/A
OCF growth 5YN/A

INTCHAINS GROUP LTD-ADR / ICG FAQ

Can you provide the ChartMill fundamental rating for INTCHAINS GROUP LTD-ADR?

ChartMill assigns a fundamental rating of 5 / 10 to ICG.


What is the valuation status for ICG stock?

ChartMill assigns a valuation rating of 0 / 10 to INTCHAINS GROUP LTD-ADR (ICG). This can be considered as Overvalued.


What is the profitability of ICG stock?

INTCHAINS GROUP LTD-ADR (ICG) has a profitability rating of 3 / 10.


How financially healthy is INTCHAINS GROUP LTD-ADR?

The financial health rating of INTCHAINS GROUP LTD-ADR (ICG) is 9 / 10.